
Anthony K. N. Chan
@anthonyknc
Researcher in Functional Genomics, Cancer Biology, and Drug Discovery, utilizing CRISPR technologies.
ID: 235876443
https://orcid.org/0000-0002-7091-1294 09-01-2011 08:15:10
126 Tweet
105 Followers
555 Following


We're excited to hear from David Chen, PhD, of City of Hope as he introduces sc-Tiling, a #CRISPR-based method for #genefunction characterization. Register here to tune in and join more innovative discussions at the CRISPR Functional Genomics Symosium! bit.ly/3vcM6Nr

Thrilled to share our work published in Nature Communications! We've developed "sc-Tiling", which integrates a sc #CRISPR gene-tiling screen with #scRNAseq and protein structural analyses to identify regulatory mechanisms within a gene-coding region! nature.com/articles/s4146…

This has been a big collaborative effort over several years. Congratulations to everyone involve including: Matthias Schiedel, @Joe_P_B, Dr Hannah Bolland, Anthony K. N. Chan, Coco Laurin, @Katrina51963799, @PascalHeitel, Robert Paton, Will Pomerantz, Pomerantz Lab, Phil Biggin 🇪🇺, @Hammond_Lab.

Today we released a preprint biorxiv.org/content/10.110… where we take a step towards the next challenge: building a nanopore single-molecule PROTEIN sequencer! 😳 Awesome experiments by postdoc Henry Brinkerhoff of our #CDlab, augmented with MD simulations of AksimentievLab 1/x







Today in partnership with Isomorphic Labs, we're sharing progress on the next generation of #AlphaFold. 🧬 Our new model greatly expands coverage of structure prediction beyond proteins to other key biomolecular classes. How could it help scientists? 🧵 dpmd.ai/alphafold-prog…

The UK medicines regulator approves the first therapy using CRISPR gene editing. Vertex Pharmaceuticals and CRISPR Therapeutics's Casgevy will treat the blood conditions sickle-cell disease and β-thalassemia #NBTNewsBeat nature.com/articles/d4158…







